Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 63304-724

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 63304-724). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Bupropion 01)

FDA Label Image

Pdp-1 (Bupropion 02)

This is a description of Once-Daily NG, a drug containing bupropion hydrochloride extended-release tablets in 300 mg doses, manufactured by Sun Pharmaceutical Industries Limited. It is a prescription drug that should not be used in combination with Zyban or other drugs containing bupropion hydrochloride. Each extended-release tablet contains 300mg of bupropion hydrochloride, and the usual dosage is one tablet per day, as directed by a physician (reference: prescribing information). The package is child-resistant, and the drug should be kept out of reach of children and stored at 20°C to 25°C (68°F to 77°F) [see USP control Room Temperature].*

FDA Label Image

Pdp-2 (Bupropion 03)

FDA Label Image

Pdp-3 (Bupropion 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.